# Insights from AAPS PharmSci 360 Live with Dr. Mark Arnold

Page: https://stenobird.com/podcast/biotalk-unzipped-6702602/insights-from-aaps-pharmsci-360-live-with-dr-mark-arnold
Text version: https://stenobird.com/podcast/biotalk-unzipped-6702602/insights-from-aaps-pharmsci-360-live-with-dr-mark-arnold.md
Podcast: [BioTalk Unzipped](https://stenobird.com/podcast/biotalk-unzipped-6702602)
Published: 2024-12-30T05:15:00+00:00
Episode link: https://biotalk-unzipped.captivate.fm/episode/insights-from-aaps-pharmsci-360-live-with-dr-mark-arnold
Audio file: https://podcasts.captivate.fm/media/cba78027-3823-45fb-8660-70e6ce775449/https-3a-2f-2fd3ctxlq1ktw2nl-cloudfront-net-2fstaging-2f2024-10.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/biotalk-unzipped-6702602/episodes/insights-from-aaps-pharmsci-360-live-with-dr-mark-arnold
Duration seconds: 1789

## Resource

In this episode of BioTalk Unzipped, host Gregory Austin and co-host Chad Briscoe engage with Dr. Mark Arnold, a distinguished bioanalytical thought leader. They discuss the impact of recent FDA regulations on drug development, the importance of community support through the Samaritan Purse charity, especially on recent hurricane victims, and the exciting advancements in RNA editing technologies. The conversation highlights the collaborative nature of the pharmaceutical industry and the drive behind bioanalytical work, emphasizing the ultimate goal of delivering effective therapies to patients. Chapters 00:00 Introduction to BioTalk Unzipped at AAPS PharmSci 360 03:45 Samaritan's Purse Charity and Community Impact 05:16 Most impactful talk at AAPS? 11:50 Comparative Analysis of FDA and EU Regulations 17:37 The Drive Behind Bioanalytical Work 22:24 NEW NEWS! - Innovations in RNA Editing and Bioanalysis Takeaways ​The FDA's new rules on lab-developed tests could delay biomarker utilization in clinical trials. ​Community support through charities like Samaritan's Purse is crucial during crises. ​The importance of collaboration in advancing drug development and bioanalytical methods. ​Innovations in RNA editing present new bioanalytical challenges. ​The drive to help patients is a key motivator for professionals in the field. ​ Sound Bites ​"I worked on that drug and there's a clear benefit." ​"It's getting that new therapy to a patient." ​"This is going to change and potentially delay biomarkers." ​ New News Story: ​Wave sees RNA editing validation in early trial results ◦https://www.biopharmadive.com/news/wave-rna-editing-aatd-first-trial-data/729981/ (https://www.biopharmadive.com/news/wave-rna-editing-aatd-first-trial-data/729981/) How to reach us: Please donate to: Sa…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/biotalk-unzipped-6702602/episodes/insights-from-aaps-pharmsci-360-live-with-dr-mark-arnold/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/biotalk-unzipped-6702602/insights-from-aaps-pharmsci-360-live-with-dr-mark-arnold.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.